Literature DB >> 23109335

IgG Fab fragments forming bivalent complexes by a conformational mechanism that is reversible by osmolytes.

Alfreda D Nelson1, Michele M Hoffmann, Christopher A Parks, Surendra Dasari, Adam G Schrum, Diana Gil.   

Abstract

Generated by proteolytic cleavage of immunoglobulin, Fab fragments possess great promise as blocking reagents, able to bind receptors or other targets without inducing cross-linking. However, aggregation of Fab preparations is a common occurrence, which generates intrinsic stimulatory capacity and thwarts signal blockade strategies. Using a panel of biochemical approaches, including size exclusion chromatography, SDS-PAGE, mass spectrometry, and cell stimulation followed by flow cytometry, we have measured the oligomerization and acquisition of stimulatory capacity that occurs in four monoclonal IgG Fabs specific for TCR/CD3. Unexpectedly, we observed that all Fabs spontaneously formed complexes that were precisely bivalent, and these bivalent complexes possessed most of the stimulatory activity of each Fab preparation. Fabs composing bivalent complexes were more susceptible to proteolysis than monovalent Fabs, indicating a difference in conformation between the Fabs involved in these two different states of valency. Because osmolytes represent a class of compounds that stabilize protein folding and conformation, we sought to determine the extent to which the amino acid osmolyte l-proline might impact bivalent Fab complexation. We found that l-proline (i) inhibited the adoption of the conformation associated with bivalent complexation, (ii) preserved Fab monovalency, (iii) reversed the conformation of preformed bivalent Fabs to that of monovalent Fabs, and (iv) separated a significant percentage of preformed bivalent complexes into monovalent species. Thus, Fab fragments can adopt a conformation that is compatible with folding or packing of a bivalent complex in a process that can be inhibited by osmolytes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23109335      PMCID: PMC3522289          DOI: 10.1074/jbc.M112.410217

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Therapeutic antibody fragments with prolonged in vivo half-lives.

Authors:  A P Chapman; P Antoniw; M Spitali; S West; S Stephens; D J King
Journal:  Nat Biotechnol       Date:  1999-08       Impact factor: 54.908

2.  Separation and isolation of fractions of rabbit gamma-globulin containing the antibody and antigenic combining sites.

Authors:  R R PORTER
Journal:  Nature       Date:  1958-09-06       Impact factor: 49.962

3.  Involvement of the same region of the T cell antigen receptor in thymic selection and foreign peptide recognition.

Authors:  J Kaye; N J Vasquez; S M Hedrick
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

4.  Potential aggregation-prone regions in complementarity-determining regions of antibodies and their contribution towards antigen recognition: a computational analysis.

Authors:  Xiaoling Wang; Satish K Singh; Sandeep Kumar
Journal:  Pharm Res       Date:  2010-04-27       Impact factor: 4.200

5.  Inhibition of protein aggregation in vitro and in vivo by a natural osmoprotectant.

Authors:  Zoya Ignatova; Lila M Gierasch
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-09       Impact factor: 11.205

Review 6.  Antibody structure, instability, and formulation.

Authors:  Wei Wang; Satish Singh; David L Zeng; Kevin King; Sandeep Nema
Journal:  J Pharm Sci       Date:  2007-01       Impact factor: 3.534

7.  Structural and functional study of rabbit polyclonal antibody for immunoassay purposes.

Authors:  Soheila Kashanian; Hadi Ravan; Sirous Ghobadi; Kobra Omidfar; Soyebeh Askari
Journal:  Hybridoma (Larchmt)       Date:  2008-02

Review 8.  Biotechnology applications of amino acids in protein purification and formulations.

Authors:  T Arakawa; K Tsumoto; Y Kita; B Chang; D Ejima
Journal:  Amino Acids       Date:  2007-03-16       Impact factor: 3.520

9.  Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha.

Authors:  D Fekade; K Knox; K Hussein; A Melka; D G Lalloo; R E Coxon; D A Warrell
Journal:  N Engl J Med       Date:  1996-08-01       Impact factor: 91.245

10.  Selective blockade of CD28 and not CTLA-4 with a single-chain Fv-alpha1-antitrypsin fusion antibody.

Authors:  Bernard Vanhove; Geneviève Laflamme; Flora Coulon; Marie Mougin; Patricia Vusio; Fabienne Haspot; Jérôme Tiollier; Jean-Paul Soulillou
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

View more
  6 in total

1.  Membrane Association Transforms an Inert Anti-TCRβ Fab' Ligand into a Potent T Cell Receptor Agonist.

Authors:  Jenny J Lin; Geoff P O'Donoghue; Kiera B Wilhelm; Michael P Coyle; Shalini T Low-Nam; Nicole C Fay; Katherine N Alfieri; Jay T Groves
Journal:  Biophys J       Date:  2020-04-23       Impact factor: 4.033

2.  Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiation.

Authors:  Laura R E Becher; Wendy K Nevala; Shari Lee Sutor; Megan Abergel; Michele M Hoffmann; Christopher A Parks; Larry R Pease; Adam G Schrum; Svetomir N Markovic; Diana Gil
Journal:  Blood Adv       Date:  2020-11-10

3.  Strategies to stabilize compact folding and minimize aggregation of antibody-based fragments.

Authors:  Diana Gil; Adam G Schrum
Journal:  Adv Biosci Biotechnol       Date:  2013-04

4.  Modification of Fab Fragments by Dibromopyridazinediones Carrying Mono- and Double-Biotin Functionalities.

Authors:  Takahiko Matsushita; Naoto Maruyama; Tetsuo Koyama; Ken Hatano; Koji Matsuoka
Journal:  ACS Omega       Date:  2022-09-14

5.  Co-potentiation of antigen recognition: A mechanism to boost weak T cell responses and provide immunotherapy in vivo.

Authors:  Michele M Hoffmann; Carlos Molina-Mendiola; Alfreda D Nelson; Christopher A Parks; Edwin E Reyes; Michael J Hansen; Govindarajan Rajagopalan; Larry R Pease; Adam G Schrum; Diana Gil
Journal:  Sci Adv       Date:  2015-10-02       Impact factor: 14.136

6.  Antibody-dependent cellular cytotoxicity targeting CD4-inducible epitopes predicts mortality in HIV-infected infants.

Authors:  Nicole E Naiman; Jennifer Slyker; Barbra A Richardson; Grace John-Stewart; Ruth Nduati; Julie M Overbaugh
Journal:  EBioMedicine       Date:  2019-09       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.